ResMed targets 59-60% gross margins and expanded global reach for AirSense 11
Q2 2025 Management View CEO Michael Farrell reported 10% global revenue growth, driven by demand across the sleep health, ...
Pharmabiz26d
ResMed launches AirSense 11, to advance digital health in sleep apnoea for Indians
ResMed, the world’s leading health technology company focused on sleep, breathing, and care delivered in the home, has launched AirSense 11 in India. The company’s next-generation Continuous Positive ...
The Financial Express25d
ResMed launches new device for patients of sleep apnea in India
ResMed on Tuesday announced that it has launched AirSense 11 in India. According to the company’s statement, it is the next-generation Continuous Positive Airway Pressure (CPAP) device designed ...
fnarena3d
ResMed: Another Positive Quarterly Surprise?
UBS makes a similar comment, stating ResMed shares are trading at 23x FY26 earnings. Although this represents a 40% premium ...